Source link : https://newshealth.biz/health-news/once-weekly-efsitora-noninferior-to-daily-insulin-in-t2d/
CHICAGO — The investigational once-weekly basal insulin analog efsitora alfa lowered A1c as effectively as daily basal insulins in people with type 2 diabetes (T2D) who require insulin, showed three trials from the QWINT global phase 3 clinical trial program. However, two of the trials showed increased mild hypoglycemia in patients treated with efsitora, which […]
The post Once-Weekly Efsitora Noninferior to Daily Insulin in T2D first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-22 22:27:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8